Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.
Clin Cancer Res
; 26(12): 2849-2858, 2020 06 15.
Article
in En
| MEDLINE
| ID: mdl-32046999
Full text:
1
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
/
Drug-Related Side Effects and Adverse Reactions
/
B7-H1 Antigen
/
Circulating Tumor DNA
/
Antineoplastic Agents, Immunological
/
Lung Neoplasms
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2020
Type:
Article